Across TCGA patient cohorts, TACSTD2 mutation is significantly associated with the RNA expression of many other genes, with 50 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible TACSTD2-associated genes across cancer lineages are ABHD17AP9, RN7SKP132, and MIR6069. Each is linked with TACSTD2 in more than 1 cancer types. Because this analysis shows association rather than direction, both TACSTD2-to-partner and partner-to-TACSTD2 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (TACSTD2→partner) and Y-score (partner→TACSTD2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKCM	ABHD17AP9 →	+0.031	+4.634	<.001	.003	3	2
UCEC	RN7SKP132 →	+0.129	+4.292	<.001	.006	3	2
SKCM	MIR6069 →	+0.465	+2.789	<.001	.008	3	2
SKCM	MTND3P5 →	+0.046	+4.039	<.001	.009	3	1
SKCM	RNA5SP55 →	+0.168	+4.212	<.001	.007	3	1
BLCA	OR10A7 →	+0.054	+6.147	<.001	.002	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 50 associations by consensus.

Exploration

TACSTD2 survival (RNA) · tumor vs normal (RNA) · all TACSTD2 data types